Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:75
|
作者
Bunch, T. Jared [1 ]
Munger, Thomas M. [1 ]
Friedman, Paul A. [1 ]
Asirvatham, Samuel J. [1 ]
Brady, Peter A. [1 ]
Cha, Yong-Mei [1 ]
Rea, Robert F. [1 ]
Shen, Win-Kuang [1 ]
Powell, Brian D. [1 ]
Ommen, Steve R. [1 ]
Monahan, Kristi H. [1 ]
Haroldson, Janis M. [1 ]
Packer, Douglas L. [1 ]
机构
[1] St Marys Hosp, Mayo Clin, Heart Rhythm Serv, Dept Internal Med,Div Cardiovasc Dis, Rochester, MN 55902 USA
关键词
catheter ablation; atrial fibrillation; hypertrophic cardiomyopathy; heart atrium; diastole;
D O I
10.1111/j.1540-8167.2008.01192.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substrate and Procedural Predictors of Outcome in Patients with Hypertrophic Cardiomyopathy. Background: Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug-refractory AF is an effective treatment, the efficacy in HCM remains to be established. Methods: Thirty-three consecutive patients (25 male, age 51 +/- 11 years) with HCM underwent pulmonary vein (PV) isolation (n = 8) or wide area circumferential ablation with additional linear ablation (n = 25) for drug-refractory AF. Twelve-lead and 24-hour ambulating ECGs, echocardiograms, event monitor strips, and SF 36 quality of life (QOL) surveys were obtained before ablation and for routine follow-up. Results: Twenty-one (64%) patients had paroxysmal AF and 12 (36%) had persistent/permanent AF for 6.2 +/- 5.2 years. The average ejection fraction was 0.63 +/- 0.12. The average left atrial volume index was 70 +/- 24 mL/m(2). Over a follow-up of 1.5 +/- 1.2 years, 1-year survival with AF elimination was 62%(Confidence Interval [CI]: 66-84) and with AF control was 75%(CI: 66-84). AF control was less likely in patients with a persistent/chronic AF, larger left atrial volumes, and more advanced diastolic disease. Additional linear ablation may improve outcomes in patient with severe left atrial enlargement and more advanced diastolic dysfunction. Two patients had a periprocedureal TIA, one PV stenosis, and one died after mitral valve replacement from prosthetic valve thrombosis. QOL scores improved from baseline at 3 and 12 months. Conclusion: Outcomes after AF ablation in patients with HCM are favorable. Diastolic dysfunction, left atrial enlargement, and AF subtype influence outcomes. Future studies of rhythm management approaches in HCM patients are required to clarify the optimal clinical approach.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 50 条
  • [11] Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
    Rozen, Guy
    Elbaz-Greener, Gabby
    Marai, Ibrahim
    Andria, Nizar
    Hosseini, Seyed Mohammadreza
    Biton, Yitschak
    Heist, E. Kevin
    Ruskin, Jeremy N.
    Gavrilov, Yulia
    Carasso, Shemy
    Ghanim, Diab
    Amir, Offer
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (13):
  • [12] Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
    Kiticaslan, F
    Verma, A
    Saad, E
    Themistoctakis, S
    Bonso, A
    Raviele, A
    Bozbas, H
    Andrews, MW
    Beheiry, S
    Hao, S
    Cummings, JE
    Marrouche, NF
    Lakkireddy, D
    Wazni, O
    Yamaji, H
    Saenz, LC
    Saliba, W
    Schweikert, RA
    Natale, A
    HEART RHYTHM, 2006, 3 (03) : 275 - 280
  • [13] Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review
    Hakeem S. K. Ha
    Nelson Wang
    Sophia Wong
    Steven Phan
    Jace Liao
    Narendra Kumar
    Pierre Qian
    Tristan D. Yan
    Kevin Phan
    Journal of Interventional Cardiac Electrophysiology, 2015, 44 : 161 - 170
  • [14] Pericarditis After Catheter Ablation for Atrial Fibrillation Predictors and Outcomes
    Yadav, Ritu
    Satti, Danish Iltaf
    Malwankar, Jui
    Lopez-Silva, Carolina
    Xu, Lillian
    Liebow-Feeser, Elana
    Akhtar, Tauseef
    Marine, Joseph E.
    Berger, Ronald
    Calkins, Hugh
    Spragg, David
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (02) : 262 - 269
  • [15] Long-term Outcomes of Catheter Ablation or Surgical Ablation to Eliminate Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
    Banna, Moustafa
    Tchou, Patrick
    Saliba, Walid
    Lindsay, Bruce D.
    Gillinov, A. M.
    Smedira, Nicholas G.
    Blackstone, Eugene H.
    Lever, Harry M.
    Wazni, Oussama M.
    CIRCULATION, 2010, 122 (21)
  • [16] Atrial Fibrillation Ablation in Patients With Hypertrophic Cardiomyopathy Long-Term Outcomes and Clinical Predictors
    Contreras-Valdes, Fernando M.
    Buxton, Alfred E.
    Josephson, Mark E.
    Anter, Elad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (14) : 1485 - 1487
  • [17] Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate
    Derejko, Pawel
    Polanska, Magdalena
    Chojnowska, Lidia
    Michalowska, Ilona
    Wojcik, Anna
    Piotrowicz, Ewa
    Lech, Agnieszka
    Klopotowski, Mariusz
    Baranowski, Rafal
    Przybylski, Andrzej
    Bilinska, Maria
    Sierpinski, Radoslaw
    Walczak, Franciszek
    Szumowski, Lukasz
    KARDIOLOGIA POLSKA, 2013, 71 (01) : 17 - 24
  • [18] Incidence and significance of early recurrence of atrial tachyarrhythmia after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Wen, S. N.
    Liu, N.
    Ruan, Y. F.
    Bai, R.
    Li, S. N.
    Du, X.
    Dong, J. Z.
    Ma, C. S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 570 - 570
  • [19] Outcomes of catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
    Zhao, Dong-Sheng
    Shen, Yi
    Zhang, Qing
    Lin, Gang
    Lu, Yi-Hua
    Chen, Bang-Tao
    Shi, Lin-Sheng
    Huang, Jian-Fei
    Lu, Hui-He
    EUROPACE, 2016, 18 (04): : 508 - 520
  • [20] Atrial Fibrillation Substrate and Catheter Ablation Outcomes in MYBPC3- and MYH7-Mediated Hypertrophic Cardiomyopathy
    Haq, Ikram U.
    Akhiyat, Nadia
    Al-Shakarchi, Nader
    Siontis, Konstantinos C.
    Mulpuru, Siva K.
    Sugrue, Alan
    Giudicessi, John
    Friedman, Paul A.
    Asirvatham, Samuel J.
    Killu, Ammar M.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (07) : 1380 - 1391